HVEM signalling at mucosal barriers provides host defence against pathogenic bacteria

Nature

Volumn 488, Issue 7410, 2012, Pages 222-225

  Shui, Jr Wen ^a   Larange, Alexandre ^a   Kim, Gisen ^a   Vela, Jose Luis ^a   Zahner, Sonja ^a   Cheroutre, Hilde ^a   Kronenberg, Mitchell ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; RECEPTOR PROTEIN; STAT3 PROTEIN; TUMOR NECROSIS FACTOR;

BACTERIUM; DEFENSE BEHAVIOR; ENZYME ACTIVITY; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNE SYSTEM; LIGAND; MORTALITY; PATHOGENICITY; SIGNALING; TUMOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; CITROBACTER RODENTIUM; COLON; COLON MUCOSA; ENTEROPATHOGENIC ESCHERICHIA COLI; GENE EXPRESSION; HOST RESISTANCE; IMMUNE RESPONSE; INNATE IMMUNITY; LYMPHOCYTE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIA;

ANIMALS; ANTIGENS, CD; BACTERIAL LOAD; CELL LINE; CITROBACTER RODENTIUM; DISEASE MODELS, ANIMAL; ENTEROBACTERIACEAE INFECTIONS; ENTEROPATHOGENIC ESCHERICHIA COLI; EPITHELIAL CELLS; ESCHERICHIA COLI INFECTIONS; GPI-LINKED PROTEINS; IMMUNITY, MUCOSAL; INTESTINES; LIGANDS; LUNG; LYMPHOCYTES; MICE; MICE, INBRED C57BL; MUCOUS MEMBRANE; PNEUMOCOCCAL INFECTIONS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, IMMUNOLOGIC; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 14; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; STREPTOCOCCUS PNEUMONIAE; SURVIVAL RATE;

BACTERIA (MICROORGANISMS); CITROBACTER RODENTIUM; ESCHERICHIA COLI; HERPESVIRIDAE; MUS; STREPTOCOCCUS PNEUMONIAE;

EID: 84864659874     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature11242     Document Type: Article

References (33)

1. Murphy, T. L. et al. Slow down and survive: enigmatic immunoregulation by BTLA and HVEM. Annu. Rev. Immunol. 28, 389-411 (2010).
2. Anderson, C. A. et al. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nature Genet. 43, 246-252 (2011).
3. Steinberg, M. W. et al. A crucial role for HVEM and BTLA in preventing intestinal inflammation. J. Exp. Med. 205, 1463-1476 (2008).
4. Mundy, R. et al. Citrobacter rodentium of mice and man. Cell. Microbiol. 7, 1697-1706 (2005).
5. Ma, C. et al. Citrobacter rodentiuminfection causes both mitochondrial dysfunction and intestinal epithelial barrier disruption in vivo: role of mitochondrial associated protein (Map). Cell. Microbiol. 8, 1669-1686 (2006).
6. LeBlanc, P. M. et al. Caspase-12 modulates NOD signaling and regulates antimicrobial peptide production and mucosal immunity. Cell Host Microbe 3, 146-157 (2008).
7. Maeda, M. et al. Murine CD160, Ig-like receptor on NK cells and NKT cells, recognizes classical and nonclassicalMHC class I and regulates NKcell activation. J. Immunol. 175, 4426-4432 (2005).
8. Anumanthan, A. et al. Cloning of BY55, a novel Ig superfamily member expressed on NK cells, CTL, and intestinal intraepithelial lymphocytes. J. Immunol. 161, 2780-2790 (1998).
9. Nakamatsu, M. et al. Role of interferon-gamma in Va141 natural killer T cellmediated host defense against Streptococcus pneumoniae infection in murine lungs. Microbes Infect. 9, 364-374 (2007).
10. Schaer, C. et al. HVEM signalling promotes colitis. PLoS ONE 6, e18495 (2011).
11. Artis, D. et al. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nature Rev. Immunol. 8, 411-420 (2008).
12. Zheng, Y. et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nature Med. 14, 282-289 (2008).
13. Pickert, G. et al. STAT3 links IL-22 signaling in intestinal epithelial cells tomucosal wound healing. J. Exp. Med. 206, 1465-1472 (2009).
14. Marsters, S. A. et al. Herpesvirus entry mediator, a member of the tumor necrosis factor receptor (TNFR) family, interacts with members of the TNFR-associated factor family and activates the transcription factors NF-kB and AP-1. J. Biol. Chem. 272, 14029-14032 (1997).
15. Jin, W. et al. Regulation of Th17 cell differentiation and EAE induction by MAP3K NIK. Blood 113, 6603-6610 (2009).
16. Liang, S. C. et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 203, 2271-2279 (2006).
17. Sugimoto, K. et al. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J. Clin. Invest. 118, 534-544 (2008).
18. Wolk, K. et al. Biology of interleukin-22. Semin. Immunopathol. 32, 17-31 (2010).
19. Zenewicz, L. A. et al. Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 29, 947-957 (2008).
20. Wolk, K. et al. IL-22 increases the innate immunity of tissues. Immunity 21, 241-254 (2004).
21. Brand, S. et al. IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. Am. J. Physiol. Gastrointest. Liver Physiol. 290, G827-G838 (2006).
22. Torchinsky, M. B. et al. Innate immune recognition of infected apoptotic cells directs T(H)17 cell differentiation. Nature 458, 78-82 (2009).
23. Tachiiri, A. et al. Genomic structure and inducible expression of the IL-22 receptor alpha chain in mice. Genes Immun. 4, 153-159 (2003).
24. Gelebart, P. et al. Interleukin 22 signaling promotes cell growth in mantle cell lymphoma. Transl. Oncol. 4, 9-19 (2011).
25. Cheung, T. C. et al. Unconventional ligand activation of herpesvirus entrymediator signals cell survival. Proc. Natl Acad. Sci. USA 106, 6244-6249 (2009).
26. Quinton, L. J. et al. Functions and regulation of NF-kB RelA during pneumococcal pneumonia. J. Immunol. 178, 1896-1903 (2007).
27. Mizgerd, J. P. et al. Animal models of human pneumonia. Am. J. Physiol. Lung Cell. Mol. Physiol. 294, L387-L398 (2008).
28. Quinton, L. J. et al. NF-kB and STAT3 signaling hubs for lung innate immunity. Cell Tissue Res. 343, 153-165 (2011).
29. Quinton, L. J. et al. Alveolar epithelial STAT3, IL-6 family cytokines, and host defense during Escherichia coli pneumonia. Am. J. Respir. Cell Mol. Biol. 38, 699-706 (2008).
30. Rooney, I. A. et al. The lymphotoxin-beta receptor is necessary and sufficient for LIGHT-mediatedapoptosis of tumor cells. J. Biol. Chem. 275,14307-14315 (2000).
31. Zaki, M. H. et al. The NLRP3 inflammasome protects against loss of epithelial integrityandmortalityduringexperimental colitis.Immunity32,379- 391(2010).
32. Lebeis, S. L. e. t. a. l. Interleukin-1 receptor signaling protects mice from lethal intestinal damage caused by the attaching and effacing pathogen Citrobacter rodentium. Infect. Immun. 77, 604-614 (2009).
33. Ishigame, H. et al. Differential roles of interleukin-17A and-17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity 30, 108-119 (2009).